Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
2 Growth Stocks to Hold for the Next Decade
03:27pm, Tuesday, 10'th Mar 2026
Intuitive Surgical is plenty able to navigate its current issues while capitalizing on growing demand for its devices. DexCom's total installed base is a fraction of its addressable market, giving it
Here's Why DexCom (DXCM) is a Strong Growth Stock
10:45am, Monday, 09'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DexCom, Inc. $DXCM Shares Sold by Alamar Capital Management LLC
03:36am, Monday, 09'th Mar 2026
Alamar Capital Management LLC lessened its position in DexCom, Inc. (NASDAQ: DXCM) by 53.3% during the undefined quarter, according to the company in its most recent disclosure with the Securities and
Bell Asset Management Ltd Buys Shares of 31,448 DexCom, Inc. $DXCM
03:36am, Monday, 09'th Mar 2026
Bell Asset Management Ltd purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Recommendation of “Moderate Buy” by Analysts
02:36am, Monday, 09'th Mar 2026
Shares of DexCom, Inc. (NASDAQ: DXCM - Get Free Report) have received a consensus rating of "Moderate Buy" from the twenty-five analysts that are covering the firm, MarketBeat reports. One analyst has
Elfun Trusts Exits Texas Instruments Inc, Impacting Portfolio by -1.57%
04:00pm, Thursday, 05'th Mar 2026
Exploring the Strategic Moves in Elfun Trusts (Trades, Portfolio)' Fourth Quarter 2025 N-PORT Filing Elfun Trusts (Trades, Portfolio) recently submitted its N-
DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further
03:05pm, Wednesday, 04'th Mar 2026
Dexcom has been outperforming its peers since our last coverage in December. I expect further progress this year, as the company's long-suffering gross margin profile is set to reverse course over the
DexCom, Inc. (DXCM) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
03:07pm, Monday, 02'nd Mar 2026
DexCom, Inc. (DXCM) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
111 Capital Buys 10,040 Shares of DexCom, Inc. $DXCM
03:05am, Monday, 02'nd Mar 2026
111 Capital grew its stake in shares of DexCom, Inc. (NASDAQ: DXCM) by 62.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,004 share
Andra AP fonden Has $6.25 Million Stock Position in DexCom, Inc. $DXCM
04:04am, Sunday, 01'st Mar 2026
Andra AP fonden raised its position in DexCom, Inc. (NASDAQ: DXCM) by 30,833.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commis
DNB Asset Management AS Acquires 803,086 Shares of DexCom, Inc. $DXCM
04:29am, Friday, 27'th Feb 2026
DNB Asset Management AS raised its holdings in shares of DexCom, Inc. (NASDAQ: DXCM) by 271.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission
Dexcom Appoints Rick Osterloh to Board of Directors
04:15pm, Thursday, 26'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Dexcom Appoints Rick Osterloh to Board of Directors.
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
08:00pm, Wednesday, 25'th Feb 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inve
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
09:15am, Wednesday, 25'th Feb 2026
Analysts feared the advent of GLP-1 medications would harm DexCom's blood glucose monitoring devices. However, as its turns out, DexCom's devices are being prescribed together with GLP-1s.
Dexcom Announces Upcoming Conference Presentation
08:30am, Wednesday, 25'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Mond
